OcuLearning › Cornea

Peripheral Corneal Thinning/Ulceration

URGENT — Cornea

Symptoms

  • acute pain, redness, and severe photophobia (puk and mooren ulcer)
  • slow, painless vision blur (terrien marginal degeneration and pmd)
  • decreased vision due to high irregular astigmatism
  • history of systemic autoimmune disease (ra, gpa, sle)
  • history of hepatitis c (linked to mooren-like ulcers)

Clinical Findings

Inflammatory (painful)

  • puk: crescent-shaped peripheral stromal thinning with an epithelial defect
  • scleritis: associated in 90% of puk cases (eye appears deep red/purple)
  • mooren ulcer: painful thinning with a characteristic "undermined" overhanging leading edge; NO scleritis

Non-inflammatory (painless)

  • terrien marginal degeneration: superior thinning; yellow lipid line; intact epithelium
  • pellucid marginal degeneration (pmd): inferior (4 to 8 o’clock) thinning; "beer belly" ectasia above thinning
  • dellen: localized bowl-shaped depression from focal dryness (e.g., next to a pinguecula)

Advanced signs

  • corneal perforation or descemetocele (bulging basement membrane)
  • vascularization or pannus crossing the area of thinning

Etiology

Systemic vasculitis (PUK)

  • rheumatoid arthritis (most common), gpa (wegener), polyarteritis nodosa, and sle

Autoimmune/infectious

  • mooren ulcer: idiopathic autoimmune keratitis; strongly linked to hepatitis c
  • staphylococcal hypersensitivity: peripheral infiltrates with a "clear limbal zone"

Degenerative/ectatic

  • terrien marginal degeneration: idiopathic thinning, typically in males
  • pellucid marginal degeneration (pmd): non-inflammatory corneal ectasia

Neurotrophic

  • non-inflammatory thinning due to cn v/vii palsy or exposure

Red Flags

  • scleral involvement: suggests life-threatening systemic vasculitis (gpa/ra)
  • rapid "melting" (keratolysis): risk of globe perforation within hours/days
  • ra patient with corneal melt: indicates 40% 10-year systemic mortality if untreated
  • hepatitis c positive: mooren-like ulcer requires antiviral treatment

Investigations

Clinical exam

  • check corneal sensation: rule out hsv and neurotrophic causes
  • slit-lamp: narrow beam to assess depth of thinning and epithelial status
  • scleral exam: check for nodules, thinning (blue hue), or posterior scleritis

Mandatory serology (vasculitis screen)

  • cbc, esr/crp, rf, anti-ccp, ana, anca (c-anca/p-anca), and spep

Infectious screen

  • hepatitis c antibody, rpr/fta-abs (syphilis), and quantiferon-tb gold

Systemic evaluation

  • urinalysis and chest ct if gpa is suspected (renal/lung involvement)

Treatment

Systemic therapy (PUK/mooren)

  • high-dose oral steroids (prednisone 1mg/kg/day) with ppi coverage
  • steroid-sparing agents: cyclophosphamide, methotrexate, or rituximab

Topical/adjunctive

  • topical cyclosporine (0.05%–2%) and judicious topical steroids
  • doxycycline 100mg bid and vitamin c 1g–2g daily (collagenase inhibition)

Surgical (impending perforation)

  • cyanoacrylate tissue adhesive (glue) or amniotic membrane graft
  • lamellar or penetrating keratoplasty for severe cases

Degenerative management

  • pmd: specialty scleral lenses or collagen cross-linking (cxl)

Clinical Pearl

peripheral ulcerative keratitis with systemic features is rheumatoid arthritis in 50% and gpa (wegener) in the rest — get rheumatology and serologies before the globe perforates.

Differential Diagnosis

  • • infectious keratitis (bacterial/fungal/acanthamoeba)
  • • herpes simplex keratitis (decreased sensation)
  • • marginal keratitis (staphylococcal)
  • • senile furrow degeneration (non-progressive thinning in elderly)

Related Cornea Conditions